VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 112 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,665,000 | +473.1% | 139,215 | +181.4% | 0.00% | +200.0% |
| Q4 2018 | $465,000 | -75.2% | 49,465 | -50.0% | 0.00% | 0.0% |
| Q3 2018 | $1,872,000 | +108.9% | 98,930 | +115.8% | 0.00% | 0.0% |
| Q2 2018 | $896,000 | +16.7% | 45,844 | +12.2% | 0.00% | 0.0% |
| Q1 2018 | $768,000 | +40.9% | 40,872 | +24.6% | 0.00% | 0.0% |
| Q4 2017 | $545,000 | +14.5% | 32,814 | +42.0% | 0.00% | 0.0% |
| Q3 2017 | $476,000 | +107.0% | 23,115 | -10.0% | 0.00% | – |
| Q2 2017 | $230,000 | -15.8% | 25,685 | +24.7% | 0.00% | – |
| Q1 2017 | $273,000 | +4.2% | 20,604 | 0.0% | 0.00% | – |
| Q4 2016 | $262,000 | +16.4% | 20,604 | +9.8% | 0.00% | – |
| Q3 2016 | $225,000 | +9.2% | 18,757 | 0.0% | 0.00% | – |
| Q2 2016 | $206,000 | +303.9% | 18,757 | +220.0% | 0.00% | – |
| Q1 2016 | $51,000 | -60.2% | 5,862 | 0.0% | 0.00% | – |
| Q4 2015 | $128,000 | – | 5,862 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $45,697,000 | 3.92% |
| ARMISTICE CAPITAL, LLC | 3,392,000 | $24,253,000 | 0.82% |
| Bellevue Group AG | 2,712,083 | $19,391,000 | 0.22% |
| NEEDHAM INVESTMENT MANAGEMENT LLC | 141,924 | $1,015,000 | 0.17% |
| XTX MARKETS LLC | 10,578 | $76,000 | 0.16% |
| Aevitas Wealth Management, Inc. | 22,150 | $158,000 | 0.12% |
| Virtus ETF Advisers LLC | 35,079 | $251,000 | 0.10% |
| HITE Hedge Asset Management LLC | 29,357 | $210,000 | 0.05% |
| LINCOLN CAPITAL CORP | 10,000 | $72,000 | 0.05% |
| CIM INVESTMENT MANAGEMENT INC | 18,745 | $134,000 | 0.04% |